Stoke Therapeutics, Inc. (STOK)
32.39
-0.70
(-2.12%)
USD |
NASDAQ |
Dec 12, 16:00
31.87
-0.52
(-1.61%)
After-Hours: 20:00
Stoke Therapeutics Research and Development Expense (Annual): 86.96M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biogen, Inc. | 1.755B |
| Janux Therapeutics, Inc. | 68.39M |
| Insmed, Inc. | 598.37M |
| Sarepta Therapeutics, Inc. | 778.47M |
| Aldeyra Therapeutics, Inc. | 48.22M |